NasdaqGM - Nasdaq Real Time Price
USD
Entrada Therapeutics, Inc. (TRDA)
4.6200
+0.0850
(+1.87%)
As of 1:56:35 PM EST. Market Open.
Trade TRDA on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreInsider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| 5AM VENTURES V, L.P. Beneficial Owner of more than 10% of a Class of Security |
Sale | Aug 7, 2026 | -- |
| BAKER BROS ADVISORS L.P. Beneficial Owner of more than 10% of a Class of Security |
Purchase | Nov 20, 2025 | -- |
| DOSHI DIPAL Chief Executive Officer |
Stock Award(Grant) | Feb 27, 2026 | 526,014 |
| DOWDEN NATHAN J President |
Sale | May 4, 2026 | 198,588 |
| MPM BIOVENTURES 2014,L.P. Beneficial Owner of more than 10% of a Class of Security |
Sale | Sep 9, 2026 | -- |
| MPM BIOVENTURES III, L.P. Beneficial Owner of more than 10% of a Class of Security |
Sale | Dec 11, 2024 | -- |
| PARMAR KUSH M Director |
Sale | Aug 10, 2026 | -- |
| SETHURAMAN NATARAJAN Officer |
Sale | May 4, 2026 | 216,317 |
| WENTWORTH KORY JAMES Chief Financial Officer |
Sale | Apr 1, 2026 | 119,010 |
| ZEIHER BERNHARDT G Director |
Purchase | May 20, 2026 | -- |
